Zoldonat 4mg Injection

The injection is administered intravenously, typically as a single dose or repeated at intervals depending on the clinical indication and patient response. Zoldonat 4mg Injection requires careful monitoring of renal function prior to and during treatment, as zoledronic acid is contraindicated in patients with severe renal impairment. Adequate hydration before administration is recommended to minimize renal toxicity.

Common adverse effects include flu-like symptoms, hypocalcemia, and transient renal function changes. Patients should be supplemented with calcium and vitamin D to prevent hypocalcemia. Caution is advised in patients with pre-existing dental conditions due to the risk of osteonecrosis of the jaw. Zoldonat 4mg Injection should be used under strict medical supervision, with dosing tailored to the specific clinical scenario to maximize therapeutic benefits while minimizing risks.